Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Krogager, Maria Lukacs; Kragholm, Kristian; Thomassen, Jesper Qvist; Sogaard, Peter; Lewis, Basil S.; Wassmann, Sven; Baumgartner, Iris; Ceconi, Claudio; Schmidt, Thomas Andersen; Kaski, Juan Carlos; Drexel, Heinz; Semb, Anne Grete; Agewall, Stefan; Niessn
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
2021
VL / 7 - BP / 557 - EP / 567
abstract
Hypokalaemia is common in patients with cardiovascular disease. In this review, we emphasize the importance of tight potassium regulation in patients with cardiovascular disease based on findings from observational studies. To enhance the understanding, we also describe the mechanisms of potassium homeostasis maintenance, the most common causes of hypokalaemia and present strategies for monitoring and management of low potassium levels. We propose elevation of potassium in asymptomatic patients with lower normal concentrations and concurrent cardiovascular disease. These proposals are intended to assist clinicians until more evidence is available.
MENTIONS DATA
Pharmacology & Toxicology
-
0 Twitter
-
0 Wikipedia
-
0 News
-
83 Policy
Among papers in Pharmacology & Toxicology
Más información
Influscience
Rankings
- BETA VERSION